Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome

Evidence of distinct disease propagating stem cells in myelodysplastic syndrome (MDS) has emerged in recent years. However, immunophenotypic characterization of these cancer stem cells remains sparse. In acute myeloid leukaemia (AML), we have previously described aberrant expression of the C‐type le...

Descripción completa

Detalles Bibliográficos
Autores principales: Toft‐Petersen, Marie, Nederby, Line, Kjeldsen, Eigil, Kerndrup, Gitte B., Brown, Gordon D., Hokland, Peter, Stidsholt Roug, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Haematological Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091626/
https://www.ncbi.nlm.nih.gov/pubmed/27612176
http://dx.doi.org/10.1111/bjh.14270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091626/
https://www.ncbi.nlm.nih.gov/pubmed/27612176
http://dx.doi.org/10.1111/bjh.14270

Ejemplares similares